Diphenhydramine HCl - CAS 147-24-0
Catalog number: 147-24-0
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C17H21NO.HCl
Molecular Weight:
291.82
COA:
Inquire
Targets:
Histamine Receptor
Description:
Diphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations.
Purity:
>98%
MSDS:
Inquire
InChIKey:
PCHPORCSPXIHLZ-UHFFFAOYSA-N
InChI:
InChI=1S/C17H21NO.ClH/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;/h3-12,17H,13-14H2,1-2H3;1H
Canonical SMILES:
CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl
1. Evaluation of the relationship between cetuximab therapy and corrected QT interval changes in patients with advanced malignancies from solid tumors
J. F. Deeken • B. Shimkus • A. Liem • D. Hill • J. Gurtler • E. Berghorn • L. Townes • H. Lu • O. Trifan • S. Zhang. Cancer Chemother Pharmacol (2013) 71:1473–1483
Cetuximab was administered as intravenous infusions at an initial dose of 400 mg/m2 administered over 120 min on day 1 (week 1) followed by a maintenance dose of 250 mg/m2 administered over 60 min weekly thereafter. The administration of the recommended premedication (diphenhydramine HCl 50 mg) was required for the first 5 doses of cetuximab. Diphenhydramine HCl 50 mg was also required to be administered during the baseline monitoring to account for any change in QT interval related to its administration.ECG monitoring was performed at screening, baseline (week 1 preceding dosing), and during week 1 to 5 of treatment. Serum concentration samples were obtained at time-matched points during the administration in week 1 to 5. Following the completion of the ECG monitoring in week 5, the addition of other therapy (e.g., chemotherapy and/or radiation therapy) was allowed as per investigator discretion. Patients who were stable or responding to cetuximab at week 9 were eligible to continue treatment off-study with cetuximab and/or other therapy.
2. Deliquescence in Binary Mixtures
Adnan K. Salameh and Lynne S. Taylor. Pharmaceutical Research, Vol. 22, No. 2, February 2005
In Fig. 3, sorption isotherms are shown for ranitidine HCl, sucrose, and three physical mixtures of ranitidine HCl and sucrose consisting of 10:90, 50:50, and 90:10 w/w blends. The physical mixtures appear to undergo deliquescence at a lower relative humidity than either of the individual components (i.e., at a unique RH that can be designated RH0mix). Furthermore, the composition of the physical mixture does not appear to influence RH0mix within experimental limitations. The same phenomenon was observed for mixtures of diphenhydramine HCl and sucrose. In this case, the individual components have similar RH0 values of 82% and 85% for diphenhydramine HCl and sucrose, respectively, whereas RH0mix was around 76% (Table II). In contrast, anhydrous lactose was found to have minimal effect on the deliquescence behavior of ranitidine HCl, and mixtures of these two components were found to deliquesce close to RH0 of ranitidine HCl, as shown in Fig. 4. For ranitidine HCl, in addition to investigating the effect of sucrose and lactose, a series of inorganic salts were also examined. For all of the salts, RH0mix was lower than RH0 of the individual components, and results are summarized in Table II.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Histamine Receptor Products


CAS 83881-51-0 Cetirizine

Cetirizine
(CAS: 83881-51-0)

Cetirizine, a second-generation antihistamine, is a major metabolite of hydroxyzine. It is a racemic selective H1 receptor inverse agonist. It is used in cutane...

CAS 1027330-97-7 A 943931

A 943931
(CAS: 1027330-97-7)

A 943931 is a potent and selective histamine H4 receptor antagonist.

CAS 140462-76-6 Olopatadine HCl

Olopatadine HCl
(CAS: 140462-76-6)

Olopatadine HCl is a histamine blocker and mast cell stabilizer with an IC50 of 559 μM for the release of histamine

CAS 362665-56-3 Tiprolisant

Tiprolisant
(CAS: 362665-56-3)

Tiprolisant is potent and selective nonimidazole inverse agonist at the histamine H3 receptor. (Ki=0.16 nM).

CAS 100130-32-3 VUF 8430 dihydrobromide

VUF 8430 dihydrobromide
(CAS: 100130-32-3)

VUF 8430 dihydrobromide is a high affinity (pKi = 7.5) and potent histamine H4 receptor full agonist (pEC50 = 7.3). VUF 8430 also has moderate affinity for H3 r...

CAS 113-69-9 Benzquinamide Hydrochloride

Benzquinamide Hydrochloride
(CAS: 113-69-9)

Benzquinamide hydrochloride is an antiemetic compound with antihistaminic, anticholinergic and sedative properties. The mechanism of action is not quite sure an...

CAS 58-33-3 Promethazine hydrochloride

Promethazine hydrochloride
(CAS: 58-33-3)

Promethazine hydrochloride is first-generation antihistamine of the phenothiazine family used as an antiallergic, in pruritus, for motion sickness and sedation,...

CAS 76963-41-2 Nizatidine

Nizatidine
(CAS: 76963-41-2)

Nizatidine is a histamine H2 receptor antagonist with IC50 of 0.9 nM, also inhibits AChE with IC50 of 6.7 μM.

Chemical Structure

CAS 147-24-0 Diphenhydramine HCl

Quick Inquiry

Verification code

Featured Items